Novel SN-38-Incorporating Polymeric Micelles, NK012, Eradicate Vascular Endothelial Growth Factor-Secreting Bulky Tumors

Cancer Research - United States
doi 10.1158/0008-5472.can-06-1605
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Novel SN-38-Incorporated Polymeric Micelle, NK012, Strongly Suppresses Renal Cancer Progression

Cancer Research
Cancer ResearchOncology
2008English

Antitumor Effect of SN-38-Releasing Polymeric Micelles, NK012, on Spontaneous Peritoneal Metastases From Orthotopic Gastric Cancer in Mice Compared With Irinotecan

Cancer Research
Cancer ResearchOncology
2008English

Vascular Endothelial Growth Factor

English

Vascular Endothelial Growth Factor

English

Distribution of Vascular Permeability Factor (Vascular Endothelial Growth Factor) in Tumors: Concentration in Tumor Blood Vessels

Journal of Experimental Medicine
MedicineAllergyImmunology
1991English

Vascular Permeability Factor (Vascular Endothelial Growth Factor) Gene Is Expressed Differentially in Normal Tissues, Macrophages, and Tumors.

Molecular Biology of the Cell
Cell BiologyMolecular Biology
1992English

Novel Regulation of Vascular Endothelial Growth Factor-A (VEGF-A) by Transforming Growth Factor Β1

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2008English

Human Herpesvirus-8-Transformed Endothelial Cells Have Functionally Activated Vascular Endothelial Growth Factor/Vascular Endothelial Growth Factor Receptor

American Journal of Pathology
Forensic MedicinePathology
2002English

A Phase II Study of NK012, a Polymeric Micelle Formulation of SN-38, in Unresectable, Metastatic or Recurrent Colorectal Cancer Patients

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy